通过天眼查大数据分析，四川宏达股份有限公司共对外投资了13家企业，参与招投标项目1694次，知识 产权方面有商标信息18条，专利信息59条，此外企业还拥有行政许可263个。 来源：金融界 宏达股份最新一期业绩显示，截至2025一季报，公司营业总收入8.22亿元、同比增长15.04%，归属净利 润3592.81万元，同比减少556.33%，扣非净利润3703.47万元，同比减少485.10%，流动比率0.782、速动 比率0.450、资产负债率83.30%。 天眼查商业履历信息显示，四川宏达股份有限公司，成立于1994年，位于德阳市，是一家以从事化学原 料和化学制品制造业为主的企业。企业注册资本203200万人民币，实缴资本203200万人民币。公司法定 代表人为乔胜俊。 金融界消息 截至2025年7月30日收盘，宏达股份（600331）报收于9.65元，下跌1.63%，换手率1.82%， 成交量37.05万手，成交金额3.59亿元。 资金流向方面，今日主力资金净流出4955.02万元，占比成交额13.81%。其中，超大单净流出4739.87万 元、占成交额13.21%，大单净流出215.15万元、占成交额0. ...

7月8日，上纬新材公告称，智元机器人通过公司及核心团队共同出资设立的持股平台，以协议转让 和要约收购的方式取得公司控制权，至少收购其63.62%股份。智元机器人成立于2023年2月，是人 形机器人头部公司。 7月28日，上纬新材年内累计涨幅超过10倍， 成为A股2025年以来首只10倍股。 2025.07. 30 微信编辑 | 小羊 上纬新材晚间公告，公司股票价格自2025年7月9日至2025年7月30日期间多次触及股票交易异常 波动及严重异常波动情形。 为维护投资者利益，公司将就股票交易波动情况进行停牌核查。 公司收 购方未来十二个月内不存在资产重组计划。截至目前，收购方智元恒岳和致远新创合伙不存在未来 12个月内对上纬新材及其子公司的资产和业务进行出售、合并、与他人合资或合作的计划，不存在 关于上纬新材拟购买或置换资产的重组计划。 第 一 财 经 持 续 追 踪 财 经 热 点 。 若 您 掌 握 公 司 动 态 、 行 业 趋 势 、 金 融 事 件 等 有 价 值 的 线 索 ， 欢 迎 提 供 。 专 用 邮 箱 ： bianjibu@yicai.com 7月30日，上纬新材收涨9.37%报92.0 ...

金融界消息 截至2025年7月30日收盘，键邦股份（603285）报收于23.89元，下跌1.97%，换手率 5.72%，成交量3.56万手，成交金额8536.37万元。 资金流向方面，今日主力资金净流出1828.50万元，占比成交额21.42%。其中，超大单净流出1214.47万 元、占成交额14.23%，大单净流出614.02万元、占成交额7.19%，中单净流出流入682.20万元、占成交 额7.99%，小单净流入1146.30万元、占成交额13.43%。 键邦股份最新一期业绩显示，截至2025中报，公司营业总收入3.07亿元、同比减少15.37%，归属净利润 6966.36万元，同比减少27.72%，扣非净利润6555.57万元，同比减少29.81%，流动比率12.911、速动比 率12.622、资产负债率7.04%。 天眼查商业履历信息显示，山东键邦新材料股份有限公司，成立于2014年，位于济宁市，是一家以从事 化学原料和化学制品制造业为主的企业。企业注册资本16000万人民币，实缴资本12000万人民币。公司 法定代表人为祁建新。 通过天眼查大数据分析，山东键邦新材料股份有限公司共对外投资了2家企业 ...

Group 1 - The core stock price of Mingyue Lens (301101) closed at 43.69 yuan, down 2.17% with a turnover rate of 2.4% and a trading volume of 45,800 hands, amounting to 202 million yuan [1] - The latest financial report for Mingyue Lens shows total operating revenue of 197 million yuan for Q1 2025, a year-on-year increase of 2.63%, and a net profit attributable to shareholders of 47.15 million yuan, up 11.70% year-on-year [1] - The company has a current ratio of 11.360, a quick ratio of 10.760, and a debt-to-asset ratio of 9.23% [1] Group 2 - Mingyue Lens has made investments in 13 companies and participated in 203 bidding projects [2] - The company holds 131 trademark registrations and 241 patent registrations, along with 18 administrative licenses [2]

Group 1 - The core viewpoint of the news is that Jilin OLED Material Co., Ltd. (奥来德) has experienced a significant decline in its financial performance, with a notable drop in revenue and net profit in the latest quarterly report [1] - As of July 30, 2025, the company's stock price closed at 18.08 yuan, down 1.04%, with a trading volume of 59,200 lots and a transaction amount of 107 million yuan [1] - The company's latest quarterly report shows total operating revenue of 153 million yuan, a year-on-year decrease of 40.71%, and a net profit attributable to shareholders of 25.44 million yuan, a year-on-year decrease of 73.23% [1] Group 2 - The company has made investments in 15 enterprises and participated in 19 bidding projects, indicating active engagement in business expansion [2] - In terms of intellectual property, the company holds 3 trademark registrations and 795 patents, along with 20 administrative licenses [2] - The company's financial ratios indicate a current ratio of 3.868, a quick ratio of 2.792, and a debt-to-asset ratio of 21.38%, reflecting a relatively strong liquidity position [1]

天眼查商业履历信息显示，肯特催化材料股份有限公司，成立于2009年，位于台州市，是一家以从事化 学原料和化学制品制造业为主的企业。企业注册资本9040万人民币，实缴资本4730万人民币。公司法定 代表人为项飞勇。 金融界消息 截至2025年7月30日收盘，肯特催化（603120）报收于39.83元，下跌1.22%，换手率7.6%， 成交量1.68万手，成交金额6734.62万元。 资金流向方面，今日主力资金净流出1141.40万元，占比成交额16.95%。其中，超大单净流出407.33万 元、占成交额6.05%，大单净流出734.06万元、占成交额10.9%，中单净流出流入433.19万元、占成交额 6.43%，小单净流入708.21万元、占成交额10.52%。 肯特催化最新一期业绩显示，截至2025一季报，公司营业总收入1.44亿元、同比增长6.75%，归属净利 润1755.51万元，同比增长20.27%，扣非净利润1739.05万元，同比增长22.71%，流动比率4.368、速动比 率3.837、资产负债率17.16%。 通过天眼查大数据分析，肯特催化材料股份有限公司共对外投资了2家企业，参与招投标项目3 ...

Core Viewpoint - Runben Biotechnology Co., Ltd. has shown significant revenue growth in its latest quarterly report, indicating a positive financial trajectory despite a recent decline in stock price [1]. Financial Performance - As of the first quarter of 2025, the company reported total revenue of 240 million yuan, representing a year-on-year increase of 44% [1]. - The net profit attributable to shareholders was 44.2 million yuan, up 24.6% year-on-year [1]. - The company's non-recurring net profit reached 38.6 million yuan, reflecting a growth of 22.85% compared to the previous year [1]. - Key financial ratios include a current ratio of 9.71, a quick ratio of 8.639, and a debt-to-asset ratio of 7.69% [1]. Stock Performance - As of July 30, 2025, the stock price closed at 33.34 yuan, down 3.22% [1]. - The trading volume was 133,200 hands, with a total transaction amount of 448 million yuan [1]. - The net inflow of main funds was 14.7 million yuan, accounting for 3.29% of the transaction amount [1]. Company Overview - Runben Biotechnology was established in 2013 and is based in Guangzhou, primarily engaged in the manufacturing of chemical raw materials and products [1]. - The company has a registered capital of 4.0459 billion yuan, with the same amount paid in [1]. - The legal representative of the company is Zhao Guiqin [1]. Investment and Intellectual Property - The company has made investments in 8 enterprises and participated in 13 bidding projects [2]. - It holds 106 trademark registrations and 109 patents, along with 64 administrative licenses [2].

Group 1 - The company, Aoke Co., Ltd. (300082), is closely monitoring national policy dynamics and development opportunities [1] - The focus is particularly on areas related to the company's main business in construction chemicals [1]

Group 1 - The company announced that its equipment maintenance was completed by late June and normal production has resumed [1] - The chemical raw materials produced by Dongyue Chemical can provide the company with green materials, enabling the development and sale of high-value-added green polypropylene products [1] - The company is being asked about its potential participation in Dongyue Chemical's 3 million tons waste plastic project, with investors advised to pay attention to company announcements for updates [1][3] Group 2 - An investor inquired about the company's performance forecast and the reasons for the expected loss due to equipment maintenance and whether normal production has resumed [3] - The investor also questioned if the chemical raw materials from Dongyue Chemical's waste plastic resource utilization project could provide a cost advantage for the company [3]

Group 1 - The core viewpoint of the article is that Changqing Technology (603125.SH) is developing new products through independent research and collaboration with well-known domestic universities and research institutions, with some products applicable for high-end photoresist production [1] - The company's product matrix does not include any products developed in collaboration with semiconductor companies [1]